Published in Br J Cancer on September 28, 2001
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 1.90
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet (2010) 1.18
Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res (2008) 1.01
Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res (2010) 0.99
Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One (2012) 0.91
Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women. PLoS One (2014) 0.89
Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment. Am J Pathol (2011) 0.87
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men. J Natl Med Assoc (2009) 0.86
Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat. Endocrinology (2007) 0.84
Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int (2015) 0.84
Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer. Front Endocrinol (Lausanne) (2013) 0.80
Pleiotropy between genetic markers of obesity and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.78
Cancer. Adv Exp Med Biol (2005) 0.77
Isoflavone Pharmacokinetics and Metabolism after Consumption of a Standardized Soy and Soy-Almond Bread in Men with Asymptomatic Prostate Cancer. Cancer Prev Res (Phila) (2015) 0.76
Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer. Genes Cancer (2013) 0.75
Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial. Nutrients (2017) 0.75
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease. PLoS One (2016) 0.75
Apigenin Modulates Insulin-like Growth Factor Axis: Implications for Prevention and Therapy of Prostate Cancer. Curr Drug Targets (2012) 0.75
The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy. Can Urol Assoc J (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer (1997) 1.69
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51
Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab (1993) 1.50
Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab (2000) 1.49
On the epidemiology of oral contraceptives and disease. Adv Cancer Res (1987) 1.30
Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab (1993) 1.26
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) (1997) 1.19
Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection. Urology (1999) 1.00
Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst (1999) 0.99
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab (2000) 0.93
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin Endocrinol Metab (2001) 0.91
The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer. BJU Int (2000) 0.87
Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer. Tech Urol (2000) 0.83
GENIES: a natural-language processing system for the extraction of molecular pathways from journal articles. Bioinformatics (2001) 6.05
The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev (1998) 5.96
Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell (2001) 5.82
Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell (1998) 5.28
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature (2000) 4.68
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet (2000) 4.57
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science (1994) 4.57
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96
Informed consent for clinical trials: a comparative study of standard versus simplified forms. J Natl Cancer Inst (1998) 3.89
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation (1992) 3.73
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res (1996) 3.23
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res (1997) 3.21
High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol (2000) 3.09
Distribution of orexin receptor mRNA in the rat brain. FEBS Lett (1998) 2.90
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet (2001) 2.84
Knowledge and attitude on screening mammography among low-literate, low-income women. Cancer (1996) 2.81
Nucleotide sequence of a ripening-related cDNA from avocado fruit. Plant Mol Biol (1990) 2.53
Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol (2000) 2.49
Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res (1999) 2.47
Case study of the effects of atmospheric aerosols and regional haze on agriculture: an opportunity to enhance crop yields in China through emission controls? Proc Natl Acad Sci U S A (1999) 2.44
Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol (1996) 2.43
Smoking status, reading level, and knowledge of tobacco effects among low-income pregnant women. Prev Med (2001) 2.40
Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response. J Bacteriol (1994) 2.37
Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol Microbiol (1995) 2.26
PartsList: a web-based system for dynamically ranking protein folds based on disparate attributes, including whole-genome expression and interaction information. Nucleic Acids Res (2001) 2.23
Sequence analysis of ripening-related cytochrome P-450 cDNAs from avocado fruit. Proc Natl Acad Sci U S A (1990) 2.17
Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun (1997) 2.14
Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol (1997) 2.13
Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol (1996) 2.13
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res (1999) 2.09
Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity (1998) 2.08
Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax (1998) 2.04
Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions. J Mol Biol (2001) 2.03
Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol (1999) 1.95
Kinectin, a major kinesin-binding protein on ER. J Cell Biol (1992) 1.87
Intervention to increase mammography utilization in a public hospital. J Gen Intern Med (1998) 1.86
Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res (2000) 1.83
RNA sequence containing hexanucleotide AAUAAA directs efficient mRNA polyadenylation in vitro. Mol Cell Biol (1985) 1.81
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Identification of a lipid transfer protein as the major protein in the surface wax of broccoli (Brassica oleracea) leaves. Arch Biochem Biophys (1994) 1.79
Organisation of the tomato polyphenol oxidase gene family. Plant Mol Biol (1993) 1.74
GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity (2001) 1.73
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology (2006) 1.73
Directly labeled DNA probes using fluorescent nucleotides with different length linkers. Nucleic Acids Res (1994) 1.71
Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU (sigma E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J Bacteriol (1995) 1.69
Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill (2013) 1.68
Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron (1998) 1.64
Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat (1995) 1.63
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol Biol Cell (2001) 1.59
Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol (1998) 1.59
Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol (1992) 1.57
Renal proximal dysfunction in patients with rheumatic diseases. Br Med J (Clin Res Ed) (1984) 1.57
Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J Virol (1994) 1.56
7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55
Kinectin, an essential anchor for kinesin-driven vesicle motility. Science (1995) 1.54
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr Biol (1996) 1.52
Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.52
Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J Bacteriol (2000) 1.50
Combining low tube voltage and iterative reconstruction for contrast-enhanced CT imaging of the chest-initial clinical experience. Clin Radiol (2013) 1.50
Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene (1997) 1.48
Regulation of the anaphase-promoting complex by the dual specificity phosphatase human Cdc14a. J Biol Chem (2001) 1.47
Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet (2000) 1.47
Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science (2000) 1.46
cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci U S A (1990) 1.46
Regulation of a restriction and modification system via DNA inversion in Mycoplasma pulmonis. Mol Microbiol (1994) 1.46
Nicastrin binds to membrane-tethered Notch. Nat Cell Biol (2001) 1.44
TP53 codon 72 polymorphism with hepatocellular carcinoma: a metaanalysis. J Int Med Res (2012) 1.43
Structure of the PI3K SH3 domain and analysis of the SH3 family. Cell (1993) 1.42
Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol (1995) 1.41
Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method. Magn Reson Med (2011) 1.41
Purification and properties of wild-type and exonuclease-deficient DNA polymerase II from Escherichia coli. J Biol Chem (1995) 1.40
Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immunoelectron microscopic evidence of secretion of this enzyme by the fungus invading the murine lung. Infect Immun (1994) 1.39
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Control of mitotic transitions by the anaphase-promoting complex. Philos Trans R Soc Lond B Biol Sci (1999) 1.36
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2007) 1.33
Evidence of altered hypothalamic pro-opiomelanocortin/ neuropeptide Y mRNA expression in tubby mice. Brain Res Mol Brain Res (1998) 1.32
cDNA cloning and expression of potato polyphenol oxidase. Plant Mol Biol (1993) 1.32
MR imaging of articular cartilage at 1.5T and 3.0T: comparison of SPGR and SSFP sequences. Osteoarthritis Cartilage (2005) 1.32
Methylation of the human telomerase gene CpG island. Cancer Res (2000) 1.31
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost (2006) 1.29
Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann Surg (2000) 1.28
GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase. Neuron (2001) 1.27
Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis (2009) 1.27
Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br J Cancer (2008) 1.26
Uterine artery embolisation combined with local methotrexate for treatment of caesarean scar pregnancy. BJOG (2010) 1.25
Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity. Microbiology (1997) 1.24
Developmental change in the voltage-dependence of the pacemaker current, if, in rat ventricle cells. Pflugers Arch (1997) 1.23
What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect (2010) 1.22
DNA polymerase III of Mycoplasma pulmonis: isolation and characterization of the enzyme and its structural gene, polC. Mol Microbiol (1994) 1.22
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res (2001) 1.22
Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med (2005) 1.22
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology (2005) 1.21
Electron diffraction studies of molecular ordering and orientation in phospholipid monolayer domains. Biophys J (1993) 1.21
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia (2010) 1.20
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem (2001) 1.20